 The funding system originally ran from April 2011 to March 2014, and was preceded by an Interim Cancer Drugs Fund from October 2010 to March 2011.Based on the size of their covered population, each strategic health authority in England was allocated fixed funds from a total £200 million per annum that was made available.The fund overspent by £30m in the year ending 2014.